How Allergists Choose Allergen Immunotherapy: A Worldwide Data-Driven Cluster Analysis
The Journal of Allergy and Clinical Immunology: In Practice · 2026-11
DOI: 10.1016/j.jaip.2026.10.040 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Allergy and Clinical Immunology: In Practice, 2026-11. Verfasst von P Demoly und 40 weiteren Autor:innen. Beteiligte Einrichtung: IDESP, UMR 1318 Univ. Montpellier - INSERM - Premedical Inria and Allergy Unit, University Hospital of Montpellier, France. Electronic address: pasca….
Abstract (Originalsprache)
BACKGROUND: Most clinical data on allergen immunotherapy (AIT) focus on efficacy and safety, whereas limited information is available on the real-world clinical drivers guiding AIT prescribing. OBJECTIVE: To identify the main drivers influencing AIT prescribing in routine practice. METHODS: This prospective, multicenter, international observational study used a web-based survey conducted in 20 countries across 8 geographic regions. Two anonymous questionnaires were completed: one by participating physicians and one for each patient initiating subcutaneous or sublingual AIT (drops or tablets) according to local standards of care. Eligible patients had IgE-mediated respiratory allergy to pollens, house dust mite, animal dander, and/or molds. Data were collected centrally and analyzed by an independent third party using descriptive statistics and cluster analysis. RESULTS: Questionnaires were obtained from 467 physicians and 11,550 patients. Physicians were predominantly allergists with substantial experience prescribing AIT. Most patients had allergic rhinitis (97.7%), and 35.6% had allergic asthma. Disease severity, patient preferences, biological activity (extract allergenic potency), and major allergen content were high-priority factors for AIT prescriptions. The most important reason for prescribing AIT was symptom reduction during treatment, followed by sustained efficacy after treatment discontinuation and, to a lesser extent, asthma prevention. Avoidance of new sensitizations was consistently rated as a low-priority factor. Cluster analysis identified six distinct prescribing patterns, highlighting marked heterogeneity in AIT selection across regions. CONCLUSION: AIT prescribing in routine clinical practice is highly heterogeneous and influenced by regional and healthcare-related factors. These real-world data provide novel insights into AIT prescribing behaviour and support the development of regional-specific, context-sensitive, patient-centered guidance.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- IDESP, UMR 1318 Univ. Montpellier - INSERM - Premedical Inria and Allergy Unit, University Hospital of Montpellier, France. Electronic address: pascal.demoly@inserm.fr.
- Allergy department, Pediatric Universitary Hospital Universitario Niño Jesus. IIS-Princesa. Fundación Hospital Niño Jesus (FIBHNJS). RICORS center RD24/0007/0037. Electronic address: prrio@yahoo.es.
- Allergy Service, Complejo Hospitalario Universitario de Santiago. Department of Psychiatry, Radiology, Public Health, Nursing and Medicine, University of Santiago de Compostela, Spain. Electronic address: carmen.vidal.p…
- IDESP, UMR 1318 Univ. Montpellier - INSERM - Premedical Inria and Allergy Unit, University Hospital of Montpellier, France. Electronic address: davide.caimmi@gmail.com.
- School of Medicine. University CEU San Pablo. Madrid. Spain. Electronic address: priconieto@gmail.com.
- Department of Allergy, Tongji Hospital, Tongji Medical College, Huazhong, University of Science and Technology, Wuhan, China. Electronic address: zrf13092@163.com.
Zitieren
APA
Demoly, P., Rodríguez Del Rio, P., Vidal, C., Caimmi, D. P., Rico Nieto, P., Zhu, R., Ali Al-Nesf, M., Larenas-Linnemann, D., Bulkhi, A., Cardet, J. C., Sánchez, J. M., Aguilar, J. A., Almendarez, C., Ashkanani, F., Caimmi, S., Chen, H., Chérrez-Ojeda, I., D'Auria, E., Dramburg, S., …, & CHOICE Survey Team (2026). How Allergists Choose Allergen Immunotherapy: A Worldwide Data-Driven Cluster Analysis. The Journal of Allergy and Clinical Immunology: In Practice. https://doi.org/10.1016/j.jaip.2026.10.040
Vancouver
Demoly P, Rodríguez Del Rio P, Vidal C, Caimmi DP, Rico Nieto P, Zhu R, et al. How Allergists Choose Allergen Immunotherapy: A Worldwide Data-Driven Cluster Analysis. The Journal of Allergy and Clinical Immunology: In Practice. 2026. doi:10.1016/j.jaip.2026.10.040
BibTeX
@article{Demoly2026,
author = {Demoly, P and Rodríguez Del Rio, P and Vidal, C and Caimmi, D P and Rico Nieto, P and Zhu, R and Ali Al-Nesf, M and Larenas-Linnemann, D and Bulkhi, A and Cardet, J C and Sánchez, J M and Aguilar, J A and Almendarez, C and Ashkanani, F and Caimmi, S and Chen, H and Chérrez-Ojeda, I and D'Auria, E and Dramburg, S and Ebisawa, M and Fusayasu, N and Gómez, M R and González-Diaz, S N and Irani, C and Kamaev, A and Katelaris, C H and Kaur, N and Kurbacheva, O and Larco, J I and Li, Mwy and Monge-Ortega, O P and Moreno, P and Pfaar, O and Pozo Beltrán, C F and Rubio, M and Sedo, G and Uriarte, S A and Yang, L and Casale, T B and Calderon, M A and CHOICE Survey Team, CHOICE Survey Team},
title = {How Allergists Choose Allergen Immunotherapy: A Worldwide Data-Driven Cluster Analysis},
journal = {The Journal of Allergy and Clinical Immunology: In Practice},
year = {2026},
doi = {10.1016/j.jaip.2026.10.040}
}
EUVIMED